Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP638769.RAFJWA5WwXFtH7yhpcLreNeV4HjTDS6j8srs2Wa2Ack60130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP638769.RAFJWA5WwXFtH7yhpcLreNeV4HjTDS6j8srs2Wa2Ack60130_assertion type Assertion NP638769.RAFJWA5WwXFtH7yhpcLreNeV4HjTDS6j8srs2Wa2Ack60130_head.
- NP638769.RAFJWA5WwXFtH7yhpcLreNeV4HjTDS6j8srs2Wa2Ack60130_assertion description "[The glutamatergic hypothesis of schizophrenia lead recently to a first successful mGlu2/3 receptor agonistic drug and is underpinned by significant findings in genes regulating the glutamatergic system (SLC1A6, SLC1A2 GRIN1, GRIN2A, GRIA1, NRG1, ErbB4, DTNBP1, DAAO, G72/30, GRM3).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP638769.RAFJWA5WwXFtH7yhpcLreNeV4HjTDS6j8srs2Wa2Ack60130_provenance.
- NP638769.RAFJWA5WwXFtH7yhpcLreNeV4HjTDS6j8srs2Wa2Ack60130_assertion evidence source_evidence_literature NP638769.RAFJWA5WwXFtH7yhpcLreNeV4HjTDS6j8srs2Wa2Ack60130_provenance.
- NP638769.RAFJWA5WwXFtH7yhpcLreNeV4HjTDS6j8srs2Wa2Ack60130_assertion SIO_000772 17982252 NP638769.RAFJWA5WwXFtH7yhpcLreNeV4HjTDS6j8srs2Wa2Ack60130_provenance.
- NP638769.RAFJWA5WwXFtH7yhpcLreNeV4HjTDS6j8srs2Wa2Ack60130_assertion wasDerivedFrom befree-2016 NP638769.RAFJWA5WwXFtH7yhpcLreNeV4HjTDS6j8srs2Wa2Ack60130_provenance.
- NP638769.RAFJWA5WwXFtH7yhpcLreNeV4HjTDS6j8srs2Wa2Ack60130_assertion wasGeneratedBy ECO_0000203 NP638769.RAFJWA5WwXFtH7yhpcLreNeV4HjTDS6j8srs2Wa2Ack60130_provenance.